CJ Bioscience, Inc. (KOSDAQ:311690)
South Korea flag South Korea · Delayed Price · Currency is KRW
8,030.00
-100.00 (-1.23%)
At close: Apr 28, 2026

CJ Bioscience Ratios and Metrics

Millions KRW. Fiscal year is Jan - Dec.
Fiscal Year
CurrentFY 2025 FY 2024 FY 2023 FY 2022 FY 2021 2020 - 2016
Period Ending
Apr '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21 2020 - 2016
Market Capitalization
104,916121,770131,831147,076170,481286,048
Upgrade
Market Cap Growth
-19.78%-7.63%-10.37%-13.73%-40.40%43.54%
Upgrade
Enterprise Value
64,48874,17998,118116,989139,502291,080
Upgrade
Last Close Price
8030.009320.0010090.0016140.0024887.5141793.85
Upgrade
PS Ratio
28.4132.9838.0326.3841.8465.56
Upgrade
PB Ratio
1.962.271.702.063.433.26
Upgrade
P/TBV Ratio
2.512.912.022.493.513.26
Upgrade
EV/Sales Ratio
17.4620.0928.3020.9834.2466.72
Upgrade
Debt / Equity Ratio
0.190.190.120.120.580.27
Upgrade
Net Debt / Equity Ratio
-0.75-0.75-0.85-0.78-0.41-0.64
Upgrade
Net Debt / EBITDA Ratio
1.951.952.202.070.696.58
Upgrade
Net Debt / FCF Ratio
1.731.732.341.860.815.98
Upgrade
Asset Turnover
0.040.040.040.060.040.05
Upgrade
Inventory Turnover
19.5019.5022.2132.5024.9010.67
Upgrade
Quick Ratio
3.553.554.104.381.433.39
Upgrade
Current Ratio
3.613.614.144.431.463.42
Upgrade
Return on Equity (ROE)
-36.54%-36.54%-44.00%-37.82%-50.78%-31.51%
Upgrade
Return on Assets (ROA)
-18.02%-18.02%-22.44%-21.95%-20.00%-6.66%
Upgrade
Return on Capital Employed (ROCE)
-42.90%-42.90%-42.20%-42.00%-58.90%-10.90%
Upgrade
Earnings Yield
-22.88%-19.71%-24.91%-15.58%-20.48%-6.74%
Upgrade
FCF Yield
-22.33%-19.24%-21.34%-20.28%-14.73%-3.28%
Upgrade
Buyback Yield / Dilution
-40.91%-40.91%-30.92%-20.52%-38.23%-10.14%
Upgrade
Source: S&P Capital IQ. Standard template. Financial Sources.